CONFERENCE REPORT

ASCO 2011: A Paradigm Shift in the Treatment of Endometrial Cancer

Interviewed by the editors of Oncology | September 23, 2011

Don Dizon, MD, Brown University, discusses the paradigm shift in the treatment of endometrial cancer with the use of medical therapy, including chemotherapy with biologics, mTOR inhibitors combined with chemotherapy, and targeted therapies.

by Arun Ilancheran | January 10, 2012 11:34 PM EST

Highly irrelevant content with respect to topic.

Agree with previous comment: What's the paradigm shift?

Cheran

by Kenneth Hodel | September 26, 2011 4:54 PM EDT

what is the paradigm shift?

ASCO 2011

ASCO 2011: Cytoreductive Surgery plus HIPEC for Metastatic Colon Cancer
October 3, 2011

ASCO 2011: Ramaswami Govindan Discusses Current and Upcoming Lung Cancer Research
August 29, 2011

ASCO 2011: Dr. Antoni Ribas Discusses the Impact of 2 New Drugs for the Treatment of Metastatic Melanoma
August 19, 2011

ASCO 2011: Steve Joffe Discusses Controversies in Phase I Clinical Trials
August 12, 2011

ASCO 2011: Nancy Dawson Discusses Screening for PSA in Prostate Cancer
August 5, 2011

PUBLICATIONS


ONCOLOGY	ONCOLOGY: Nurse Edition	CANCER MANAGEMENT: A Multidisciplinary Approach

TOPIC INDEX

Cancer Types
Breast Breast (HER2+) Breast (Triple-Negative) CML Colorectal Gastrointestinal GIST Genitourinary Gynecologic Head & Neck	Hematology Kidney (Renal Cell) Leukemia Lung Lymphoma Melanoma Multiple Myeloma Ovarian Prostate Sarcoma
Supportive Care	More Topics
Bone Metastases End-of-Life Care Palliative Care	Ethics in Oncology Practice Management Practice & Policy